AJICAP Second Generation: Improved Chemical Site-Specific Conjugation Technology for Antibody–Drug Conjugate Production
Author:
Affiliation:
1. Ajinomoto Co., Inc., 1-1, Suzuki-Cho, Kawasaki-Ku, Kawasaki-Shi, Kanagawa 210-8681, Japan
2. Ajinomoto Bio-Pharma Services, 11040 Roselle Street, San Diego, California 92121, United States
Publisher
American Chemical Society (ACS)
Subject
Organic Chemistry,Pharmaceutical Science,Pharmacology,Biomedical Engineering,Bioengineering,Biotechnology
Link
https://pubs.acs.org/doi/pdf/10.1021/acs.bioconjchem.3c00040
Reference37 articles.
1. Site-selective modification strategies in antibody–drug conjugates
2. An overview of process development for antibody-drug conjugates produced by chemical conjugation technology
3. DS-8201a, A Novel HER2-Targeting ADC with a Novel DNA Topoisomerase I Inhibitor, Demonstrates a Promising Antitumor Efficacy with Differentiation from T-DM1
4. The Latest Research and Development into the Antibody–Drug Conjugate, [fam-] Trastuzumab Deruxtecan (DS-8201a), for HER2 Cancer Therapy
5. Recent Advances in Drug–Antibody Ratio Determination of Antibody–Drug Conjugates
Cited by 12 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Site-selective template-directed synthesis of antibody Fc conjugates with concomitant ligand release;Chemical Science;2024
2. Antibody-drug conjugates in cancer therapy: innovations, challenges, and future directions;Archives of Pharmacal Research;2023-12-28
3. Affinity‐Directed Site‐Specific Protein Labeling and Its Application to Antibody‐Drug Conjugates;Advanced Science;2023-11-30
4. Bispecific Antibodies Produced via Chemical Site-Specific Conjugation Technology: AJICAP Second-Generation;ACS Medicinal Chemistry Letters;2023-11-21
5. Novel formats of antibody conjugates: recent advances in payload diversity, conjugation, and linker chemistry;Expert Opinion on Biological Therapy;2023-11-02
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3